Korea finished drug market growth driven by generics

Jul 10, 2018

FDF launches at CPhI Korea as country set to become regional hub The Korean pharma market is experiencing significant growth in finished drug products, according to CPhI Korea. Over the last 12 months, market conditions have spurred a strong expansion in exports of finished formulations, driven primarily by an expanding domestic generics market. South Korea’s domestic companies are transitioning quickly to an export-oriented stance. According to the Korean Pharmaceutical Traders Association (KPTA), the export of domestic finished products is growing with a total volume of $2.6 billion in 2017. Domestic APIs are also seeing steady growth with a total volume ...

Read More

CPhI Korea 2018

May 31, 2018

Dates: 28-30 August 2018 Location: COEX, Seoul, Korea Korea – Pharmaceutical Powerhouse of the Future! CPhI Korea – hosted by UBM EMEA and co-organised with the UBM Korea Corporation and Korea Pharmaceutical Traders Association (KPTA) – is set to return to Seoul on the 28th-30th August 2018 for its fifth year in a row. The trade show is experiencing a huge surge in interest; with over 5,000 pharma professionals from 50 different countries envisaged to converge at the COEX centre during the three-day event. According to KPTA, the export of domestic finished products is experiencing strong growth with total volume ...

Read More